TABLE 1.
Demographic and Clinical Characteristics of Patients and Overview of Lesion Analyses
| Patient | Sex | Age (y) | Cancer type | Lesion site | Lesions analyzed (n) | SUVpeak (30 min) | TNR-B (30 min) | SUVpeak (90 min) | TNR-B (90 min) |
| 1 | F | 59 | Breast | Bone | 16 | 1.23 ± 0.4 | 2.33 ± 0.8 | 1.27 ± 0.3 | 1.46 ± 0.4 |
| 2 | F | 55 | Breast | Bone, uterus | 9 | 1.53 ± 0.5 | 2.18 ± 0.6 | 1.42 ± 0.4 | 1.58 ± 0.4 |
| 3 | M | 77 | RCC | Muscle | 1 | 1.59 | 1.52 | 1.52 | 1.62 |
| 4* | F | 58 | ALL | NA | NA | NA | NA | NA | NA |
| 5 | F | 59 | CML | Bone marrow | 1 | 3.23 | 3.32 | 2.12 | 1.89 |
*Patient with evidence of disease in blood and bone marrow at time of study inclusion but no evidence of disease at time of imaging.
TNR-B: tumor-to-blood ratio; RCC = renal cell cancer; ALL = Philadelphia chromosome-positive pre-B acute lymphoblastic leukemia; NA = not applicable; CML = chronic myelogenous leukemia.